Phio Pharmaceuticals Corp PHIO

NAS: PHIO | ISIN: US71880W2044   17/05/2024
0,787 USD (+7,44%)
(+7,44%)   17/05/2024
Grafiek Phio Pharmaceuticals Corp Grafiek Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corp in het nieuws

13 oktober 2023 · Thinking about buying stock in T2 Biosystems, Lucid Group, Femasys, Groupon Inc, or Phio Pharmaceuticals? · Persbericht

12 oktober 2023 · Thinking about buying stock in Phio Pharmaceuticals, Barrick Gold, Clearmind Medicine, Athersys Inc, or Wheeler Real Estate Investment Trust? · Persbericht

2 juni 2023 · Phio Pharmaceuticals Announces Closing of $4 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules · Persbericht

31 mei 2023 · Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules · Persbericht

24 mei 2023 · Phio Pharmaceuticals Announces Initiation of Collaborative Clinical Trial with PH-762, AgonOx's Tumor Infiltrating Lymphocyte Program (AGX148) and Providence Cancer Institute · Persbericht

18 mei 2023 · Phio Pharmaceuticals Presents Preclinical Study Showing INTASYL™ Treatment of NK Cells More than Doubles Ability to Kill Tumor Cells · Persbericht

16 mei 2023 · Phio Pharmaceuticals Announces FDA Clearance to Initiate Clinical Trial of PH-762 for Treatment of Skin Carcinomas · Persbericht

11 mei 2023 · Phio Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update · Persbericht

20 april 2023 · Phio Pharmaceuticals Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules · Persbericht

18 april 2023 · Phio Pharmaceuticals Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules · Persbericht

Profiel Phio Pharmaceuticals Corp

Biotechnologie
Fabricage van farmaceutische preparaten
Gezondheidstechnologie
Productie

Website: phiopharma.com

Hoofdzetel: Marlborough, Massachusetts vlag Verenigde Staten

CEO: Gerrit Dispersyn

Werknemers: 9

Aandelen Phio Pharmaceuticals Corp

Beurswaarde: 3,61 miljoen USD

Effecten: 4,59 miljoen

Beta: 0,86

Mijn selecties